NCT07136701View on ClinicalTrials.gov

Risk Factors, Prognosis, Clinicopathological and Metabolic Characteristics of EO- vs LO-PanNETs

Not yet recruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

July 31, 2027

Conditions
Pancreatic Neuroendocine Neoplasms (pNETs)
Trial Locations (1)

Unknown

Qilu Hospital of Shandong University, Jinan

All Listed Sponsors
collaborator

China-Japan Friendship Hospital

OTHER

collaborator

The Affiliated Hospital of Qingdao University

OTHER

collaborator

Qianfoshan Hospital

OTHER

lead

Qilu Hospital of Shandong University

OTHER

NCT07136701 - Risk Factors, Prognosis, Clinicopathological and Metabolic Characteristics of EO- vs LO-PanNETs | Biotech Hunter | Biotech Hunter